We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -1.37% | 18.00 | 17.50 | 18.50 | 18.50 | 18.00 | 18.25 | 336,970 | 12:53:13 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.34 | 16.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
01/3/2017 09:28 | "This could create the potential for revenue streams...including sale of the strain as an ingredient by manufacturers and royalties..." I'm still not writing them of selling IP for a huge price. This stock is definitely worth investing in. A punt yes, but the opportunities are absolutely huge. | colinzeal | |
01/3/2017 09:23 | 1bokke. I thought Real Ale did already? Fair comment. lukead, correct. However, please also trail through the AEO thread and you will find MM and myself had totally opposing views on that Co. | pj 1 | |
01/3/2017 09:14 | PJ1 you need to understand the journey the company has been on to understand why this news is worthy of an Rns. I would agree that the launch of an additional product might be considered business as usual if the company already had a range of similar products in the market but considering where Opti are in their development, this rns is validation of all the developments we have been hearing about. I.E new product launch in the spring... Adding an ingredient to a range of foods that lowers cholesterol will be a marketing depts wet dream, imagine being told that your favorite food now improves your health! | 1bokke | |
01/3/2017 09:02 | PJ1 set up the TRAK thread, where MichaelMouse resides, how cosy. | lukead | |
01/3/2017 09:02 | A successful long term company is based on solid foundations. This RNS is part of that. | misconduct | |
01/3/2017 08:58 | pj1 - as you seem to lack diamond - good ;) | scotty1 | |
01/3/2017 08:57 | The calm before the storm, I am not going to say a word. | diamond fibre | |
01/3/2017 08:54 | Simply because it pays to look at both sides of a coin, a skill most BB posters seem to lack. | pj 1 | |
01/3/2017 08:50 | Pj1 after reading your posts again i'd question why you posted them. | scotty1 | |
01/3/2017 08:49 | Well said trotters - all the ducks are being lined up. If you can't see where this is going then more fool you. A cholesterol product effective as statins and reduces hypertension - how is that not ever going to be a success. I'm very confident OPTI will make me a lot of money someday, the only question I don't know the answer to is when. But that when is getting a lot closer by the day. | woodaldo | |
01/3/2017 08:49 | Sorry Trotters but after reading your Post above, CTAG definitely springs to mind | pj 1 | |
01/3/2017 08:47 | After reading the RNS again I'd ask the question why have they RNS'd it? Its just normal business imo | pj 1 | |
01/3/2017 08:43 | Marnewton, your pictures paint a thousand words. More importantly, I can understand them! | rafboy | |
01/3/2017 08:43 | Last year we were notified of development stages as regards products and divisions. And now, as promised, these are coming to fruition - products gone and going to market, an Asian conglomerate partner, splintering of divisions (Skinbiotics. having relocated); of course there are no profits as yet. Would share price be where it is, if profits were clocking up? Two things are disappointing however; that MN deal has gone silent and that despite promises, for most part, being met, share price languishes around 75% of value that held prior to any of the de-risking we have witnessed over the past year. I'd have thought £1 was a reasonable risk-based value a year ago - always provided one put credence in the message SOH was sending out. And even he, prior to all this de-risking, had expressed the view that £2.00 seemed to him s fair price. And if, once again, he's to be believed (and volumes of scientific evidence supports him) the sky is the limit so-wise, why is it we're stuck even to-day with fresh much anticipated further de-risking news in the offing, we remain stuck on 70p. this, surely to-day, is a bargain entry value? | owenmo | |
01/3/2017 08:36 | It reads as a load of Flannel to me FWIW. If they have then why not just say it? This cloak and dagger approach rarely turns out as Investors expect. If they have these agreements already in place then why not just bloody well say it? I do have a small long position here, but these sort of RNS's remind me of CTAG a little. Can anyone name any Co that RNS it was attending a trade show and launching products, that actually won anything at them? I cannot. | pj 1 | |
01/3/2017 08:35 | Dunno how else you could read it. Certainly more than mere froth. But then I'm just a humble chartist...more used to pictures;¬) M | marnewton | |
01/3/2017 08:31 | It would be very good if that is correct. | rafboy | |
01/3/2017 08:23 | I agree with Parob. It reads to me that there are European deals that are done deals. M | marnewton | |
01/3/2017 08:21 | This is positive news but not new news to anyone who has researched the company well. This has been discussed on the bb here for a few days. Must admit slightly confused by the RNS, do we have partners and products ready for launch? | rafboy | |
01/3/2017 08:13 | Froth. Encouraging froth but froth all the same as there's no hard commercialisation announced or in sight. I continue to hold but am disappointed we haven't seem some monetisation (other than the GoFigure range) of IP to date. | rollthedice | |
01/3/2017 08:13 | JH - this will come, I hope people can see that the building blocks are going into place and areas of the business are being de-risked. | primal123 | |
01/3/2017 08:12 | I guess the market is still waiting for the potential revenue streams to be turned into actual revenue streams. But definitely a big step in the right direction. | bernieboy | |
01/3/2017 08:09 | Good news, but not the news that will grab the markets attention. | john henry |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions